Mountaineer-Phase ll (ACCRU)
Clinical Trial Grant
Awarded By
Seattle Genetics, Inc
Start Date
September 16, 2019
End Date
November 14, 2024
Awarded By
Seattle Genetics, Inc
Start Date
September 16, 2019
End Date
November 14, 2024